Table 2.
Cancer type (# participants) | Total symptom score Mean (SE) | Percent with symptom | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Tiredness/ lack of energy |
Difficulty sleeping |
Decreased sexual interest |
Dry mouth |
Low back pain |
Sore muscles |
Heartburn/ belching |
Tingling | Cough | Shortness of breath |
Problems controlling urine |
||
Biliary tract, liver & pancreas (30) | 41.8 (1.9) | 79% | 59% | 62% | 45% | 52% | 55% | 59% | 41% | 28% | 41% | 50% |
Esophagus (47) | 40.6 (1.7) | 68% | 52% | 41% | 45% | 45% | 43% | 50% | 45% | 40% | 53% | 30% |
Thymus (l0) | 40.5 (3.1) | 70% | 50% | 50% | 40% | 60% | 60% | 50% | 60% | 40% | 50% | 20% |
Hematologic (24) | 40.1 (2.8) | 78% | 52% | 59% | 43% | 52% | 43% | 27% | 58% | 43% | 43% | 39% |
Breast (20) | 40.1 (1.8) | 83% | 65% | 72% | 56% | 39% | 61% | 39% | 44% | 39% | 33% | 33% |
Gynecologic (13) | 39.8 (3.1) | 62% | 69% | 67% | 46% | 46% | 58% | 31% | 50% | 38% | 15% | 0% |
Stomach (20) | 39.7 (2.0) | 80% | 60% | 37% | 45% | 50% | 53% | 60% | 40% | 20% | 35% | 35% |
Small bowel & colon (8) | 39.5 (4.5) | 57% | 29% | 29% | 29% | 29% | 29% | 29% | 29% | 14% | 29% | 14% |
Sarcoma (54) | 39.2 (1.4) | 72% | 43% | 62% | 42% | 53% | 47% | 38% | 42% | 34% | 32% | 51% |
Head/neck | 38.1 (1.3) | 65% | 54% | 43% | 78% | 33% | 37% | 29% | 23% | 45% | 20% | 25% |
Kidney & bladder (48) | 36.2 (1.4) | 65% | 42% | 40% | 38% | 40% | 30% | 33% | 31% | 30% | 30% | 33% |
Testis & prostate (15) | 32.1 (1.8) | 40% | 13% | 13% | 27% | 27% | 27% | 20% | 27% | 7% | 27% | 33% |
All participants (309) | 39.0 (10.2) | 70% | 50% | 48% | 47% | 45% | 44% | 40% | 39% | 35% | 35% | 34% |
Total mean symptom score was calculated by summing response values across all 28 symptoms; possible score range from 28–112.